GILD — Gilead Sciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapSuper Stock

Annual balance sheet for Gilead Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2017 December 31st	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	25,510	30,089	24,352	7,408	6,520
Net Total Accounts Receivable
Net Total Receivables	3,851	3,327	3,582	4,892	4,493
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	31,823	35,836	30,296	15,996	14,772
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3,295	4,006	5,170	5,613	5,663
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	70,283	63,675	61,627	68,407	67,952
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	11,635	10,605	9,759	11,397	11,610
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	49,841	42,288	39,102	50,205	46,883
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	20,442	21,387	22,525	18,202	21,069
Total Liabilities & Shareholders' Equity	70,283	63,675	61,627	68,407	67,952
Total Common Shares Outstanding

Discover the metrics influencing Gilead Sciences's share price